NSEOutcome of Board Meeting3d ago · 17 Aug 2026, 03:05 pm
Outcome of Board Meeting
Shree Ram Proteins Limited · SRPL
✦ AI SummaryResults
Shree Ram Proteins Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a loss of Rs. 636.40 lakhs, compared to a loss of Rs. 299.83 lakhs in the previous quarter.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Shree Ram Proteins Limited has submitted to the Exchange, the standalone financial results for the period ended June 30, 2026 alongwith limited review report
Attachments (1)
📄pdf
Download →
SRPL_17082026150219_outcome.pdf
View document text
d SHREE RAM PROTEINS LTD. JAS-ANZ
—— Fact : Survey No.
Dist. Rjkot - 2605347 35 | Fox 291
SHREE RAM mprofeins.com
——proteins ltd=—
web: www.shreeramproteins.cor Corporate Identity Number (CIN)
L01405G)J2008PLC054913
17-08-2026
The Manager, Listing
National Stock Exchange of India Limited
Exchange Plaza,
Bandra Kurla
Complex Bandra (E), Mumbai - 400051
Subject: Outcome of the Board Meeting held on 17t August, 2026.
Ref: Shree Ram Proteins Limited (Symbol: -SRPL, ISIN: INE008Z01012)
Dear Sir/Madam,
In pursuance of relevant regulations of the SEBI (Listing Obligations and Disclosure Requirement),
Regulations 2015, we hereby inform you that Meeting of the Board of Directors held on August 17, 2026
commenced at 2:00 P.M at registered office of the company and concluded at 2:50 P.M. has inter alia:
1. Considered, approved and adopted the unaudited financial results of the Company for the quarter
ended 30t June, 2026.
The Un-Audited Financial Results of the Company for the quarter ended June 30, 2026 along with the
Limited Review Report by the Statutory Auditors’ thereon is enclosed with outcome as Annexure -I.
2. Considered, approved and adopted the audited financial results of the Company for the quarter and
year ended 315t March, 2026.
The Audited Financial Results of the Company for the quarter and year ended March 31st, 2026 along
with the Audit Report by the Statutory Auditors’ thereon is enclosed with outcome as Annexure -II.
Kindly take the same on record and suitably disseminated to all concerned. This intimation is also being
made available at the website of the Company ie. https://www.shreeramproteins.com/ under
investors section.
Thanking you.
Yours faithfully,
For, Shree Ram Proteins Limited
Lalitkumar Chandulal Vasoya
Chairman & Managing Director
DIN: 02296254
Place: Rajkot
PAN No.:- AAMCS4021J, GST No.:- 24AAMCS4021J1ZE, IEC No.:- 2408004926, TAN No.:- RKTS05847C
SHREE RAM PROTEINS LIMITED
Regd. Office: SPACE ODYSSEY Office NO.604, 150 Feet Ring Rd, Suryoday Society, Rajkot, Gujarat 360005
CI 01405GJ2008PLC054913
STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30th JUNE,2026
(Rs. in lakhs)
Corresponding | Previous Year
Quarter Ended Quarter Ended Ended
Particulars
30.06.2026 31.03.2026 30.06.2075 31.03.2026
(Unaudited) (Audited) (Unaudited) (Audited)
INCOME
I_[Revenue from Operations - - =
IT_[Other Income 4017 6 137 2.63
i Total Income (L+1T) 140.17 1.46 137 283
EXPENSES
Cost of materials consumed - - - -
Purchases of stock-in-trade - - - -
Changes in inventories of finished goods, work-in-progress . i) .
V' [and stock-in-trade
Employee benefit expense 4,08 507 53 17.98
Finance Costs 720.57 - - 1.06
| D (Oe tp hr ee rc i Ea xt pi eo nn s aensd amortisation expense 28 ..7 96 241 44 .1 13 8 21 14 .. 91 33 265 76. .5 81 9
Total Expenses (IV) 77633 26338 183.84 36344
v ;‘;t):fit 7 (Loss) before exceptional items and tax (111~ (636.16) (261.92) (18247) (as0.e1)
VI_|Exceptional Ttems - - 613.92
VIt cln)’fit/ (loss) after exceptions items and befor tax (V- (636.16) (26192) (18247) (974.53)
Tax Expense
VI [(1) Current Tax(including tax expense of prior years) = - x
(2) Deferred Tax [F2] 3751 ©53] 3637
IX[Profit / (Loss) for the period from continuing
Operations(VII-VIIT) (636.40)| (299.83) (181.94) (1,010.85)
XX I_ _|P [r To af xi t E/ x( pL eo nss s) e f or fo dm i sd ci os nc to in nt ui in nu gi n og p eO rp ae tr ia ot ni so n -3 -= e - x -
XII [Profit / (Loss) from discontinuing Operations (after N R R R
tax) (X-XI)
XIIT |Profit/(loss) for the period (IX+XIT) (636.40) (299.83) (181.94) (1,010.85)
Other Comprehensive Income
[A.()Items that wil not be reclassifled to profit o [oss (0.95) (10.09) 2.10 G78)]
(ii)income tax relating to items that will not be reclassiied 0% 25 053 i~
XIV |t6o. p(rio)fIittem osr tlhoasts wil be rediassiied (o profit or loss z o = =
pro( fi itn i on rc o lm ose s tax relating to items that will be reclassified to N . - -
Total Comprehensive Income for the period.
XV |(XILI+XIV) Comprising Profit (Loss) and Other (637.11) (307.38) (180.37), (1,013.68)
comprehensive Income for the period )
Paid-up Equity Share Capital - 214 Bridd
(Face Value Rs. 1 Each) (Refer Note 5) et 21420 il Hsas
Earnings per equity share (for continuing operation):
M 1) Basic ©30) (©.14) (0.08) ©a7)
(2) Diluted (0.30) (0.19) (0.08) (0.47)
Earnings per equity share (for discontinued
v [operation)
1) Basic - - -
(2) Diluted 7 5 .
Earning per equity share (for discontinued &
v [continuing operation)
1) Basic (0.30) (0.14)} (0.08) (0.47)]
(2) Diluted (0.30) (0.14)] (0.08) (047)
SHREE RAM PROTEINS LIMITED
Jewetof
MANAGING DIRECTOR
Notes to the financial results:
The Company's Unaudited financial resuts for the quarter ended June 30, 2026 have been reviewed by the Audit Committee and subsequently
approved & taken on record by the Board of Directors of the Company at its meeting held on 17th August, 2026, The Statutory Auditors of the
Company have carried out a limited review of these results,
T prh ie n ciU pn la eu sd i lat ie d d df oi wna nn ci ia nl tr he es ul It ns d if ao nr t Ah ce c oq uu na tr it ne gr Se tn ad ne dd a rJ du sn e 3 43 0 ", I n2 t0 e2 r6 im h Fa iv ne a nb cie ae ln Rp er pe op ra tr ie nd g” in ( *a Ic nc do r Ad Sa n 3c 4e " )w i pt rh e st ch re i br ee dc o ugn ni dt ei ro n s ea cn td io nm e 1a 3s 3u r oe fm e Tn ht e
Companies Act , 2013 and other recognised accounting practices and the policies to the extend applicable.
Figures of previous reporting periods have been regrouped/redassiied wherever necessary to correspond with the figures of the current reporting
period.
The Company's Operations fall under a single segment "Solvent Products". Hence, segment reporting is not applicable as per Indian Accounting
Standard (AS) - 108 Operating Segments.
The Company has accepted a one-time settlement(OTS) of dues pending for its secured loans with Union Bank of India vide letter dated 24/02/25,
The Company has made a payment of Rs. 242.50 Lakhs as first instalment towards such a settlement up front. However, the Company has failed
to make the payment of Rs. 376.25 Lakhs towards 2nd installment due on within 15 days from OTS acknowledgement date and final installment
which is due on 31/03/2025 of Rs. 1856.25 lakhs,
The Company is currently in the process of raising additional funds for its business operations.The Company is currently facing a shortage of
working capital due to an increase in the working capital cycle of the Company and is in default o its covenants on its bank loans and has not paid
various statutory dues to the government.
During the vear dated 18/05/2026 Union Bank of India sold xheSPfirit{ af%qudxam W?)WTW gv tmrl IF( . 382,00 Lakh,
For and on behalf of Board of DlrecBrs
Lalitkumar Vasdya N AGING DIRECTOR
Date : 17.08.2026 Managing Director
Place : Rajkot DIN -02296254
H. B. KALARIA & ASSOCIATES A-B01/602, The Imperial Heights, 150 Ft. Ring Road,
Chartered Accountants Opp. Big Bazaar, Rajkot - 380 004.
INDEPENDENT AUDITOR’S REVIEW REPORT ON REVIEW OF INTERIM
FINANCIAL RESULTS
Board of Directors,
Shree Ram Proteins Limited
1. We have reviewed the accompanying statement of Unaudited financial results
of Shree Ram Proteins Limited (“the Company") for the quarter ended June
30, 2026 ("the statement") attached herewith, being submitted by the Company
pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015 as amended.
2. This statement, which is the responsibility of the Company’s management and
has been approved by the Company’s Board of Directors or Committee of Board
of Directors, has been compiled from the related financial statements which
has been prepared in accordance with the recognition and measurement
principles laid down In the Indian Accounting Standard 34 “Interim Financial
Reporting” (“Ind AS 34”) prescribed under Section 133 of the Companies Act,
2013 read with relevant rules issued thereunder (Ind AS) and other
[Showing first 8,000 characters — download PDF for full document]